Healthcare company-building profile
JLABS @ Washington, DC
Johnson & Johnson Innovation with Children's National Hospital
AcceleratorPharma acceleratorCorporateActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Pharma accelerator
- Organization
- Johnson & Johnson Innovation with Children's National Hospital
- Organization type
- Corporate
- Location
- Washington, District of Columbia
- Company stage served
- Research or idea stage to Early stage
- Cohort or participation model
- Rolling residency; flexible-term lab and office leases
- Investment or funding offered
- Not publicly documented
- Published investment terms
- No equity or IP rights required as a condition of residency
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2021
Public description
About the program
JLABS @ Washington, DC was established with Children's National Hospital on its Research & Innovation Campus, giving early-stage companies wet-lab residency next to a major pediatric academic medical center. The site emphasizes pediatric and rare disease innovation alongside the broader JLABS therapeutic scope. Residency is offered without J&J taking equity or IP.
What the program publicly emphasizes
Focus areas and features
Pediatric health innovationBiotech and therapeuticsMedical devicesDigital health
- Category: Pharma accelerator
- Program structure: Rolling residency; flexible-term lab and office leases
- Published terms: No equity or IP rights required as a condition of residency
Sources
External source links open in a new tab.